Request A Personalized Demo
Let us show you how HealthWorksAI can optimize your Medicare Advantage product design efforts at every stage through actionable insights by leveraging public and private healthcare data.
Slowing Growth, Structural Shifts, and the Rise of Specialized Plans
A comprehensive analysis of enrollment trends, competitive dynamics, SNP expansion, and plan type evolution across the Medicare Advantage landscape.
The Medicare Advantage (MA) market entered 2026 in a markedly different phase than the rapid expansion years that followed the pandemic. While total enrollment continues to grow—reaching nearly 29.6 million Individual MA beneficiaries and 5.7 million Group MA members—the pace of expansion has clearly moderated.
Yet beneath this topline deceleration lies a far more dynamic story. Enrollment mix is shifting away from traditional Non-SNP products toward specialized and higher-acuity segments, particularly Dual-Eligible (D-SNP) and Chronic (C-SNP) plans. Local HMOs have strengthened their dominance, while PPO momentum has cooled. At the same time, market leadership is being reshaped, with select growth-focused carriers capturing share as several legacy incumbents experience meaningful attrition.
This analysis provides a comprehensive 2026 view of the MA landscape—examining national trends, state-level dynamics, segment performance across MA-Only and MAPD, Special Needs Plans (SNPs), and plan type evolution. Drawing on enrollment data from the Centers for Medicare & Medicaid Services (CMS), the report highlights where growth is accelerating, where pressure is building, and how competitive positioning is evolving across the market.
The MA market is still growing—but the era of rapid acceleration has transitioned into moderate expansion.
Performance overview 2022 – 2026
Year-over-year growth peaked at over 7% in 2023–2024 before slowing to 4.6% in 2025 and further decelerating to just 3.1% in 2026. Net additions declined from ~839K in 2023 to under 150K in 2026.
| Plan Type | Members | Share | Δ |
|---|---|---|---|
| Renewal Plan | 19.3M | 65.2% | -1.3% |
| Renewal w/ SAR | 4.2M | 14.2% | +0.5% |
| Renewal w/ SAE | 1.7M | 5.7% | -2.5% |
| New Plan | 2.2M | 7.3% | +2.6% |
| Consolidated Renewal | 2.1M | 7% | +0.3% |
| Initial Contract | 195K | 0.7% | +0.5% |
Renewal Plans dominate at 65.2%, though declining from 72.9% peak. Renewal Plans with SAR surged from 1.6% (2023) to 14.2% (2026), signaling major portfolio restructuring.
Regional performance comparison
Growth by volume per state
Top carrier market performance
Carrier growth vs loss (2025-2026)
Three of the top five payors saw declines—most notably UnitedHealth (-725K) and Elevance (-318K). Humana delivered a breakout year with ~20% YoY growth (+1M members).
Group Plans
Individual MA is still growing—though decelerating—while Group MA has shifted from expansion to early-stage decline.
Performance overview for group-specific plans
Group MA grew steadily in 2023 (+5.9%) and 2024 (+5.4%). Growth slowed sharply in 2025 to +0.5%. In 2026, enrollment declined by 0.7%, resulting in a net loss of ~39K members—the first contraction.
Regional enrollment volume comparison
State-level growth vs loss (2025-2026)
Market share comparison for top carriers
Carrier growth vs loss (2025-2026)
UnitedHealth remains largest at 1.63M but declined ~12% YoY. Humana delivered ~26% growth (+153K members).
Segment Analysis
Standalone MA is gaining momentum while MAPD remains structurally dominant but decelerating.
Performance overview for MA-Only specific plans
Performance overview for Medicare Advantage Prescription Drug plans
Year-over-Year growth trend comparison (2023-2026)
Standalone MA accelerated meaningfully in 2026, growing 13% YoY—outpacing MAPD for the third consecutive year. MAPD growth has moderated from 7–8% to just 3% in 2026.
States with highest Year-over-Year growth percentage
Regional growth performance for MAPD plans
Enrollment comparison by major carrier (2025 vs 2026)
Enrollment comparison by major carrier (2025 vs 2026)
Medica stood out in MA-Only with 44% YoY growth. In MAPD, Humana gained 21% while UnitedHealth (-4%) and Elevance (-19%) declined.
Special Needs Plans
The MA market is clearly tilting toward higher-acuity, targeted segments.
Annual shift in Special Needs Plan enrollment mix
C-SNP more than tripled its share from 1.7% (2022) to 5.5% (2026). D-SNP rose from 17.1% to 21.5%. Non-SNP declined from 80.9% to 72.6%.
Market performance with static labels and colored tooltips
| State | 2025 | 2026 | Net Change |
|---|---|---|---|
| California | 2.2M | 2.2M | -20K |
| Florida | 1.9M | 1.9M | -30K |
| Texas | 1.5M | 1.5M | -10K |
| Pennsylvania | 1.1M | 1.1M | -15K |
| New York | 1.0M | 1.0M | +10K |
| Payor | 2025 | 2026 | Net Change |
|---|---|---|---|
| Humana | 3.9M | 4.7M | +833K |
| UnitedHealth | 5.5M | 4.9M | -609K |
| CVS Health | 3.2M | 3.0M | -186K |
| Kaiser | 1.7M | 1.7M | +20K |
| Elevance | 1.8M | 1.5M | -306K |
Performance overview in brand primary theme
| State | 2025 | 2026 | Net Change |
|---|---|---|---|
| New York | 700K | 790K | +90K |
| Florida | 620K | 650K | +30K |
| California | 580K | 610K | +30K |
| Texas | 450K | 480K | +30K |
| Puerto Rico | 300K | 320K | +20K |
| Payor | 2025 | 2026 | Net Change |
|---|---|---|---|
| UnitedHealth | 1.8M | 1.7M | -96K |
| Humana | 900K | 1.0M | +140K |
| Elevance | 600K | 570K | -30K |
| CVS Health | 500K | 480K | -20K |
| Centene | 400K | 420K | +20K |
New York led with 12.8% growth. Humana delivered strongest AEP performance (+140K). UnitedHealth recorded highest AEP loss (-96K).
Chronic Condition Special Needs Plan - Primary Brand Theme
| State | 2025 | 2026 | Net Change |
|---|---|---|---|
| Florida | 200K | 252K | +52K |
| Texas | 150K | 210K | +60K |
| California | 120K | 170K | +50K |
| Illinois | 80K | 115K | +35K |
| S. Carolina | 60K | 90K | +30K |
| Payor | 2025 | 2026 | Net Change |
|---|---|---|---|
| UnitedHealth | 350K | 333K | -17K |
| Humana | 180K | 238K | +58K |
| Elevance | 100K | 130K | +30K |
| Alignment | 70K | 95K | +25K |
| Devoted | 3K | 58K | +55K |
Florida led with +51.8K AEP additions. Devoted delivered breakout momentum (+55K, 1,685% YoY). Humana added ~58K with 53% growth.
Institutional Special Needs Plan performance summary
| State | 2025 | 2026 | Net Change |
|---|---|---|---|
| New York | 18K | 19K | +500 |
| California | 12K | 12K | +200 |
| Florida | 10K | 10K | +100 |
| Texas | 9K | 9K | +200 |
| Pennsylvania | 7K | 7K | -100 |
| Payor | 2025 | 2026 | Net Change |
|---|---|---|---|
| UnitedHealth | 45K | 42K | -3K |
| Rifkin | 8K | 10K | +2K |
| Mitchell Family | 5K | 5K | +200 |
| Longevity Health | 5K | 5K | +300 |
| SNP Holdings | 3K | 3K | +100 |
I-SNP remains niche and relatively stable. UnitedHealth dominates but saw the highest net decline (-2.7K). Growth concentrated among smaller specialized operators.
Plan Type
The MA market is clearly tilting toward higher-acuity, targeted segments.
Distribution across HMO, PPO, and Special Plan Types
| Plan Type | Enrollment | YoY Change | Net Change |
|---|---|---|---|
| Local HMO | 19.5M | +7% | +416,427 |
| Local PPO | 9.75M | -0.12% | -342,415 |
| Regional PPO | 97K | -33% | -48,047 |
| Cost | 189K | +21% | +32,843 |
| PFFS | 70K | -5% | -3,713 |
| MSA | 1.3K | +64% | +498 |
Historical and projected HMO plan performance summary
Texas led momentum. Humana added ~490K members (16% YoY). Elevance saw the sharpest decline (-252K, -17%).
Comparative analysis of PPO plan performance and growth trends
Why HealthworksAI
Be first. Be right. (Not either/or)
Fastest signal → action
County precision, not averages
Benefits that actually convert
20-min readout: top counties, rival moves, benefit levers, commission signals.
Insights from CMS Landscape (<36h turnaround)